IP advocacy group Ideas Matter showcased the pivotal role of IP in the development of cancer treatments at an event in London today. Representatives from a number of companies active in the field of cancer diagnostics attempted to counter the arguments put forward by IP sceptics by explaining the importance of IP to funding, product development, cross-industry collaboration and ultimately improving the quality of life for cancer sufferers.

Want to read more?

Register to access two of our subscriber-only articles per month

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts

Already registered? Log in

What our customers are saying

Very impressed. Clear, usable insights into the business of IP, and particularly awareness of new strategic IP concepts and tools. I also find it effective for helping frame IP issues with clients and benchmarking to IAM best practice examples. Compares well with the LES journal, and both together cover a broad and thorough toolkit for any IP-centric businessperson.

David Todd
President/IP strategy consultant
Isentient Technologies Corp


Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.

Why subscribe?